BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2014 9:24:00 PM | Browse: 1515 | Download: 1600
 |
Received |
|
2014-05-28 12:07 |
 |
Peer-Review Started |
|
2014-05-28 21:09 |
 |
To Make the First Decision |
|
2014-07-09 12:10 |
 |
Return for Revision |
|
2014-07-17 15:03 |
 |
Revised |
|
2014-08-27 10:51 |
 |
Second Decision |
|
2014-11-10 11:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-11-19 09:16 |
 |
Articles in Press |
|
2014-11-19 09:43 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-11-20 18:16 |
 |
Typeset the Manuscript |
|
2014-12-11 15:32 |
 |
Publish the Manuscript Online |
|
2014-12-20 19:42 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ting-Ting Li, Shuji Ogino and Zhi Rong Qian |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
United States National Institute of Health (NIH) |
P01 CA87969 (to SE Hankinson) |
United States National Institute of Health (NIH) |
UM1 CA167552 |
United States National Institute of Health (NIH) |
P01 CA55075 (to WC Willett) |
United States National Institute of Health (NIH) |
R01 CA137178 (to AT Chan) |
United States National Institute of Health (NIH) |
P50 CA127003 (to CS Fuchs) |
United States National Institute of Health (NIH) |
R01 CA151993 (to S Ogino) |
Bennett Family Fund for Targeted Therapies Research |
|
Entertainment Industry Foundation through National Colorectal Cancer Research Alliance |
|
|
Corresponding Author |
Zhi-Rong Qian, MD, PhD, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Room M420, Boston, MA 02215, United States. zhirong_qian@dfci.harvard.edu |
Key Words |
Toll-like receptor; Colorectal cancer; Carcinogenesis; Prognosis; Cancer therapy |
Core Tip |
Toll-like receptors (TLRs) are innate immune sensors which can recognize inflammatory mediators. TLRs have been shown to mediate inflammatory response and maintain epithelial barrier homeostasis. Inflammation is a risk factor for many cancers including colorectal cancer (CRC). The key molecules involved in inflammation-driven carcinogenesis include TLRs. In this paper, we reviewed TLR signaling in CRC from carcinogenesis to cancer therapy.
|
Publish Date |
2014-12-20 19:42 |
Citation |
Li TT, Ogino S, Qian ZR. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. World J Gastroenterol 2014; 20(47): 17699-17708 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i47/17699.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i47.17699 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345